It takes over $2.5B and 10 years to produce one drug. Artificial Intelligence has the power to halve each of that. Enter, BenevolentAI.
Akili Interactive using AR technology to treat Alzheimer’s Disease, Depression and ADHD
Using data to discover treatments faster
Despite remarkable scientific progress in recent decades, current funding models for projects in early-stage drug development and climate change have failed. These projects tend to be expensive, risky, and lengthy. Andrew Lo and his colleagues at MIT suggest that crowdfunding and financial engineering can provide the solution to this funding problem.